Cargando…
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial
BACKGROUND: Impaired insight poses a challenge in the treatment of patients with schizophrenia because of its potential to jeopardize therapeutic engagement and medication adherence. This study explored how insight impairment, graded from none to extreme, is related to patient-reported mental health...
Autores principales: | Lysaker, Paul H., Weiden, Peter J., Sun, Xiaowu, O’Sullivan, Amy K., McEvoy, Joseph P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420291/ https://www.ncbi.nlm.nih.gov/pubmed/36031632 http://dx.doi.org/10.1186/s12888-022-04190-w |
Ejemplares similares
-
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
por: McEvoy, Joseph P., et al.
Publicado: (2021) -
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome, Leslie, et al.
Publicado: (2019) -
Insight, Neurocognition, and Schizophrenia: Predictive Value of the Wisconsin Card Sorting Test
por: Stratton, John, et al.
Publicado: (2013) -
Effectiveness of lurasidone in schizophrenia or schizoaffective patients
switched from other antipsychotics: a 6-month, open-label, extension study
por: Citrome, Leslie, et al.
Publicado: (2013) -
Autobiographical memory and mentalizing impairment in personality disorders and schizophrenia: clinical and research implications
por: Dimaggio, Giancarlo, et al.
Publicado: (2012)